RE:RE:RE:Patricia Andrews...Interesting that Patricia A , has previous experience with Incyte.
Not talked about much, Onc has an on- going ongoing mbc trial with Incyte.
Many interwoven stories unfolding.
They are certainly re- grouping.
They need a B.D. Deal.
mangement knows that, the B.O.D. Knows that.
Will Patricia make a difference?
imho her background similar to the last two BOD appointed all come from business development world.
I was on a B.O.D for 4 years.
nothing at all related to biotech. However, enough expierence to understand the process.
long story short, most deals are done long before getting to the board, for final approval.
Also a solid B.O.D. Can bring pedigree & substance to negotiations.
meaning it is who you know that counts.
Patricia can certainly draw on her contacts within the biotech pharma world to open some some doors.
iMHO a great addition.